Role of platelets in progressive glomerular diseases
Authors:
- 1 August 1995
- journal article
- review article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 9 (4) , 495-502
Abstract
There is increasing evidence that platelets are involved in the pathogenesis of glomerulonephritis. Intraglomerular platelets or their degradation products are observed in biopsies from patients with lupus nephritis, mesangioproliferative, membranous or IgA nephropathy. Moreover shortened platelet survival in patients with various glomerular diseases has also been described. In models of experimental glomerulonephritis, platelets may participate in glomerular injury, together with other mediators, by complex mechanisms. As extensively documented, platelets release within the glomerulus vasoactive, chemotactic and mitogenic substances that interact with a number of soluble mediators generated by renal resident or inflammatory cells and contribute to amplify glomerular injury. Thus platelet-activating factor and other platelet secretory products, polycationic macromolecules, platelet factor 4 and β-thromboglobulin, alter glomerular permeability to proteins and enhance immune-mediated glomerular injury. Platelet-derived factors, like platelet-derived growth factor (PDGF) and transforming growth factor β (TGFβ) mediate renal disease progression in experimental and human glomerulonephritis via their chemotactic activity for infiltrating leucocytes and their effect of promoting extracellular matrix synthesis by resident renal cells. In these settings increased renal expression of PDGF and TGFβ has correlated with clinical features. Specific PDGF and TGFβ inhibitors ameliorated experimental glomerular disease. A wide variety of therapies to inhibit platelet function have been employed over the years, however the results of clinical studies are controversial and do not allow conclusions to be drawn about the efficacy of anti-platelet agents in progressive renal disease. Identification of specific platelet inhibitors or interventions specific for platelet secretory products and their target cells will be crucial for understanding the exact role of platelets and their products in glomerular disease.Keywords
This publication has 82 references indexed in Scilit:
- TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathyKidney International, 1994
- Autocrine secretion of transforming growth factor-β in cultured rat mesangial cellsKidney International, 1992
- Platelets and blood vessels: the adhesion eventImmunology Today, 1992
- Increased urinary excretion of platelet activating factor in mice with lupus nephritisLife Sciences, 1991
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- Effect of the Antiplatelet Agents Ticlopidine and Dipyridamole on Nephrotoxic Serum Nephritis in RatsNephron, 1987
- Human platelet cationic proteins bind to rat glomeruli, induce loss of anionic charges and increase glomerular permeabilityInflammation Research, 1985
- Membranoproliferative GlomerulonephritisNew England Journal of Medicine, 1984
- Effects of Sulindac and Ibuprofen in Patients with Chronic Glomerular DiseaseNew England Journal of Medicine, 1984
- Coagulation and renal diseaseKidney International, 1972